Factors associated with viral suppression among adults living with HIV on antiretroviral therapy in Nigeria: Analysis of a population‐based survey, 2018
Objective Viral load suppression (VLS) is critical in reducing morbidity and mortality associated with HIV as well as minimizing the likelihood of HIV transmission to uninfected persons. The objective of this study was to identify factors associated with VLS among people living with HIV (PLWH) on an...
Gespeichert in:
| Veröffentlicht in: | HIV medicine 2023-07, Vol.24 (7), p.827-837 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 837 |
|---|---|
| container_issue | 7 |
| container_start_page | 827 |
| container_title | HIV medicine |
| container_volume | 24 |
| creator | Abimiku, Alash'le Ramadhani, Habib Omari Moloney, Mirna Stafford, Kristen Alyce Chang, Joy Chih‐Wei Patel, Hetal Kiritkumar Domaoal, Robert A. Okoye, McPaul Jelpe, Tapidiyel Bronson, Megan Ibrahim, Dalhatu Swaminathan, Mahesh Gambo, Aliyu Charurat, Manhattan E. |
| description | Objective
Viral load suppression (VLS) is critical in reducing morbidity and mortality associated with HIV as well as minimizing the likelihood of HIV transmission to uninfected persons. The objective of this study was to identify factors associated with VLS among people living with HIV (PLWH) on antiretroviral (ARV) therapy to inform HIV programme strategies in Nigeria.
Methods
Adult participants, aged 15–64 years, from the 2018 Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS), who self‐reported to be a PLWH or had detectable ARVs, were analysed to examine factors associated with VLS defined as HIV RNA |
| doi_str_mv | 10.1111/hiv.13485 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11195444</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2833865524</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4445-5ea3890c450270db9839dece7777004c82bd49578abbcb5782e8dfdcf63f68923</originalsourceid><addsrcrecordid>eNp1kc1u1TAQhSMEoqWw4AWQJTYgkdZ_SexuUFVRWqkqG2BrOY5zr6vcOHicVNnxCKx5vD5JfW9KVZDwZmzN5zNHc7LsNcGHJJ2jtZsOCeOieJLtE16KnFDJnu7uPKdlSfeyFwDXGJOKSfw822Ol5AURbD_7faZN9AGQBvDG6WgbdOPiGk0u6A7BOAzBAjjfI73x_QrpZuwioM5NLr126PnFd7Tt99EFG4Nfvsa1DXqYkevRlVvZ4PQxOul1N4MD5Fuk0eCHsdMxad_-_FVrSKNhDJOdPyCKiXiZPWt1B_bVfT3Ivp19-np6nl9--XxxenKZG855kRdWMyGx4QWmFW5qKZhsrLFVOhhzI2jdcFlUQte1qVOlVjRtY9qStaWQlB1kHxfdYaw3tjG2j8m_GoLb6DArr536u9O7tVr5SaXVyyJ5SArv7hWC_zFaiGrjwNiu0731IyhaCVkRzClO6Nt_0Gs_hrSWRAnGRFkUdCv4fqFM8ADBtg9uCN6OJSpFrnaRJ_bNY_sP5J-ME3C0ADeus_P_lVTKcZG8A1zbuZY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2833865524</pqid></control><display><type>article</type><title>Factors associated with viral suppression among adults living with HIV on antiretroviral therapy in Nigeria: Analysis of a population‐based survey, 2018</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Abimiku, Alash'le ; Ramadhani, Habib Omari ; Moloney, Mirna ; Stafford, Kristen Alyce ; Chang, Joy Chih‐Wei ; Patel, Hetal Kiritkumar ; Domaoal, Robert A. ; Okoye, McPaul ; Jelpe, Tapidiyel ; Bronson, Megan ; Ibrahim, Dalhatu ; Swaminathan, Mahesh ; Gambo, Aliyu ; Charurat, Manhattan E.</creator><creatorcontrib>Abimiku, Alash'le ; Ramadhani, Habib Omari ; Moloney, Mirna ; Stafford, Kristen Alyce ; Chang, Joy Chih‐Wei ; Patel, Hetal Kiritkumar ; Domaoal, Robert A. ; Okoye, McPaul ; Jelpe, Tapidiyel ; Bronson, Megan ; Ibrahim, Dalhatu ; Swaminathan, Mahesh ; Gambo, Aliyu ; Charurat, Manhattan E. ; NAIIS study group ; the NAIIS study group</creatorcontrib><description>Objective
Viral load suppression (VLS) is critical in reducing morbidity and mortality associated with HIV as well as minimizing the likelihood of HIV transmission to uninfected persons. The objective of this study was to identify factors associated with VLS among people living with HIV (PLWH) on antiretroviral (ARV) therapy to inform HIV programme strategies in Nigeria.
Methods
Adult participants, aged 15–64 years, from the 2018 Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS), who self‐reported to be a PLWH or had detectable ARVs, were analysed to examine factors associated with VLS defined as HIV RNA <1000 copies/mL. NAIIS measured HIV prevalence, viral load, ARV and hepatitis B in PLWH. Logistic regression models were used and reported weighted prevalence.
Results
Of 1322 participants, 949 (68.25%) were women and 1287 (96.82%) had detectable ARVs. The median age was 39.31 [interquartile range (IQR): 31.47–47.63] years. Prevalence of VLS was 80.88%. Compared with participants with detectable ARVs, those with undetectable ARVs in their blood specimens had lower odds of VLS [adjusted odds ratio (aOR) = 0.24, 95% confidence interval (CI): 0.08–0.64). Coinfection with hepatitis B and nonnucleoside reverse transcriptase inhibitor metabolites were also associated with lower odds of VLS. Older people (45–54 vs 15–24 years) had increased odds of VLS (aOR = 2.81, 95% CI: 1.14–6.90).
Conclusion
Young people and those with undetectable ARVs had lower odds of virological suppression. Targeted interventions focusing on young people and adherence to medication are needed to achieve the UNAIDS 95–95‐95 goals for HIV epidemic control.</description><identifier>ISSN: 1464-2662</identifier><identifier>ISSN: 1468-1293</identifier><identifier>EISSN: 1468-1293</identifier><identifier>DOI: 10.1111/hiv.13485</identifier><identifier>PMID: 36945183</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Acquired immune deficiency syndrome ; Acquired Immunodeficiency Syndrome - drug therapy ; Adolescent ; Adult ; Aged ; AIDS ; antiretroviral ; Antiretroviral agents ; Antiretroviral therapy ; Confidence intervals ; Disease transmission ; Epidemics ; Female ; Hepatitis ; Hepatitis B ; Hepatitis B - drug therapy ; HIV ; HIV Infections - drug therapy ; HIV Infections - epidemiology ; Human immunodeficiency virus ; Humans ; Male ; Metabolites ; Morbidity ; Nigeria - epidemiology ; Non-nucleoside reverse transcriptase inhibitors ; Older people ; people living with HIV ; Public health ; Regression analysis ; Regression models ; Reverse Transcriptase Inhibitors - therapeutic use ; RNA-directed DNA polymerase ; Statistical analysis ; survey ; Surveys ; Viral Load ; viral suppression ; Young adults</subject><ispartof>HIV medicine, 2023-07, Vol.24 (7), p.827-837</ispartof><rights>2023 British HIV Association.</rights><rights>2023 British HIV Association</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4445-5ea3890c450270db9839dece7777004c82bd49578abbcb5782e8dfdcf63f68923</citedby><cites>FETCH-LOGICAL-c4445-5ea3890c450270db9839dece7777004c82bd49578abbcb5782e8dfdcf63f68923</cites><orcidid>0000-0001-9372-9359 ; 0000-0001-5620-6436 ; 0000-0002-0629-9459</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fhiv.13485$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fhiv.13485$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,780,784,885,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36945183$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Abimiku, Alash'le</creatorcontrib><creatorcontrib>Ramadhani, Habib Omari</creatorcontrib><creatorcontrib>Moloney, Mirna</creatorcontrib><creatorcontrib>Stafford, Kristen Alyce</creatorcontrib><creatorcontrib>Chang, Joy Chih‐Wei</creatorcontrib><creatorcontrib>Patel, Hetal Kiritkumar</creatorcontrib><creatorcontrib>Domaoal, Robert A.</creatorcontrib><creatorcontrib>Okoye, McPaul</creatorcontrib><creatorcontrib>Jelpe, Tapidiyel</creatorcontrib><creatorcontrib>Bronson, Megan</creatorcontrib><creatorcontrib>Ibrahim, Dalhatu</creatorcontrib><creatorcontrib>Swaminathan, Mahesh</creatorcontrib><creatorcontrib>Gambo, Aliyu</creatorcontrib><creatorcontrib>Charurat, Manhattan E.</creatorcontrib><creatorcontrib>NAIIS study group</creatorcontrib><creatorcontrib>the NAIIS study group</creatorcontrib><title>Factors associated with viral suppression among adults living with HIV on antiretroviral therapy in Nigeria: Analysis of a population‐based survey, 2018</title><title>HIV medicine</title><addtitle>HIV Med</addtitle><description>Objective
Viral load suppression (VLS) is critical in reducing morbidity and mortality associated with HIV as well as minimizing the likelihood of HIV transmission to uninfected persons. The objective of this study was to identify factors associated with VLS among people living with HIV (PLWH) on antiretroviral (ARV) therapy to inform HIV programme strategies in Nigeria.
Methods
Adult participants, aged 15–64 years, from the 2018 Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS), who self‐reported to be a PLWH or had detectable ARVs, were analysed to examine factors associated with VLS defined as HIV RNA <1000 copies/mL. NAIIS measured HIV prevalence, viral load, ARV and hepatitis B in PLWH. Logistic regression models were used and reported weighted prevalence.
Results
Of 1322 participants, 949 (68.25%) were women and 1287 (96.82%) had detectable ARVs. The median age was 39.31 [interquartile range (IQR): 31.47–47.63] years. Prevalence of VLS was 80.88%. Compared with participants with detectable ARVs, those with undetectable ARVs in their blood specimens had lower odds of VLS [adjusted odds ratio (aOR) = 0.24, 95% confidence interval (CI): 0.08–0.64). Coinfection with hepatitis B and nonnucleoside reverse transcriptase inhibitor metabolites were also associated with lower odds of VLS. Older people (45–54 vs 15–24 years) had increased odds of VLS (aOR = 2.81, 95% CI: 1.14–6.90).
Conclusion
Young people and those with undetectable ARVs had lower odds of virological suppression. Targeted interventions focusing on young people and adherence to medication are needed to achieve the UNAIDS 95–95‐95 goals for HIV epidemic control.</description><subject>Acquired immune deficiency syndrome</subject><subject>Acquired Immunodeficiency Syndrome - drug therapy</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>AIDS</subject><subject>antiretroviral</subject><subject>Antiretroviral agents</subject><subject>Antiretroviral therapy</subject><subject>Confidence intervals</subject><subject>Disease transmission</subject><subject>Epidemics</subject><subject>Female</subject><subject>Hepatitis</subject><subject>Hepatitis B</subject><subject>Hepatitis B - drug therapy</subject><subject>HIV</subject><subject>HIV Infections - drug therapy</subject><subject>HIV Infections - epidemiology</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Male</subject><subject>Metabolites</subject><subject>Morbidity</subject><subject>Nigeria - epidemiology</subject><subject>Non-nucleoside reverse transcriptase inhibitors</subject><subject>Older people</subject><subject>people living with HIV</subject><subject>Public health</subject><subject>Regression analysis</subject><subject>Regression models</subject><subject>Reverse Transcriptase Inhibitors - therapeutic use</subject><subject>RNA-directed DNA polymerase</subject><subject>Statistical analysis</subject><subject>survey</subject><subject>Surveys</subject><subject>Viral Load</subject><subject>viral suppression</subject><subject>Young adults</subject><issn>1464-2662</issn><issn>1468-1293</issn><issn>1468-1293</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kc1u1TAQhSMEoqWw4AWQJTYgkdZ_SexuUFVRWqkqG2BrOY5zr6vcOHicVNnxCKx5vD5JfW9KVZDwZmzN5zNHc7LsNcGHJJ2jtZsOCeOieJLtE16KnFDJnu7uPKdlSfeyFwDXGJOKSfw822Ol5AURbD_7faZN9AGQBvDG6WgbdOPiGk0u6A7BOAzBAjjfI73x_QrpZuwioM5NLr126PnFd7Tt99EFG4Nfvsa1DXqYkevRlVvZ4PQxOul1N4MD5Fuk0eCHsdMxad_-_FVrSKNhDJOdPyCKiXiZPWt1B_bVfT3Ivp19-np6nl9--XxxenKZG855kRdWMyGx4QWmFW5qKZhsrLFVOhhzI2jdcFlUQte1qVOlVjRtY9qStaWQlB1kHxfdYaw3tjG2j8m_GoLb6DArr536u9O7tVr5SaXVyyJ5SArv7hWC_zFaiGrjwNiu0731IyhaCVkRzClO6Nt_0Gs_hrSWRAnGRFkUdCv4fqFM8ADBtg9uCN6OJSpFrnaRJ_bNY_sP5J-ME3C0ADeus_P_lVTKcZG8A1zbuZY</recordid><startdate>202307</startdate><enddate>202307</enddate><creator>Abimiku, Alash'le</creator><creator>Ramadhani, Habib Omari</creator><creator>Moloney, Mirna</creator><creator>Stafford, Kristen Alyce</creator><creator>Chang, Joy Chih‐Wei</creator><creator>Patel, Hetal Kiritkumar</creator><creator>Domaoal, Robert A.</creator><creator>Okoye, McPaul</creator><creator>Jelpe, Tapidiyel</creator><creator>Bronson, Megan</creator><creator>Ibrahim, Dalhatu</creator><creator>Swaminathan, Mahesh</creator><creator>Gambo, Aliyu</creator><creator>Charurat, Manhattan E.</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-9372-9359</orcidid><orcidid>https://orcid.org/0000-0001-5620-6436</orcidid><orcidid>https://orcid.org/0000-0002-0629-9459</orcidid></search><sort><creationdate>202307</creationdate><title>Factors associated with viral suppression among adults living with HIV on antiretroviral therapy in Nigeria: Analysis of a population‐based survey, 2018</title><author>Abimiku, Alash'le ; Ramadhani, Habib Omari ; Moloney, Mirna ; Stafford, Kristen Alyce ; Chang, Joy Chih‐Wei ; Patel, Hetal Kiritkumar ; Domaoal, Robert A. ; Okoye, McPaul ; Jelpe, Tapidiyel ; Bronson, Megan ; Ibrahim, Dalhatu ; Swaminathan, Mahesh ; Gambo, Aliyu ; Charurat, Manhattan E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4445-5ea3890c450270db9839dece7777004c82bd49578abbcb5782e8dfdcf63f68923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Acquired immune deficiency syndrome</topic><topic>Acquired Immunodeficiency Syndrome - drug therapy</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>AIDS</topic><topic>antiretroviral</topic><topic>Antiretroviral agents</topic><topic>Antiretroviral therapy</topic><topic>Confidence intervals</topic><topic>Disease transmission</topic><topic>Epidemics</topic><topic>Female</topic><topic>Hepatitis</topic><topic>Hepatitis B</topic><topic>Hepatitis B - drug therapy</topic><topic>HIV</topic><topic>HIV Infections - drug therapy</topic><topic>HIV Infections - epidemiology</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Male</topic><topic>Metabolites</topic><topic>Morbidity</topic><topic>Nigeria - epidemiology</topic><topic>Non-nucleoside reverse transcriptase inhibitors</topic><topic>Older people</topic><topic>people living with HIV</topic><topic>Public health</topic><topic>Regression analysis</topic><topic>Regression models</topic><topic>Reverse Transcriptase Inhibitors - therapeutic use</topic><topic>RNA-directed DNA polymerase</topic><topic>Statistical analysis</topic><topic>survey</topic><topic>Surveys</topic><topic>Viral Load</topic><topic>viral suppression</topic><topic>Young adults</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Abimiku, Alash'le</creatorcontrib><creatorcontrib>Ramadhani, Habib Omari</creatorcontrib><creatorcontrib>Moloney, Mirna</creatorcontrib><creatorcontrib>Stafford, Kristen Alyce</creatorcontrib><creatorcontrib>Chang, Joy Chih‐Wei</creatorcontrib><creatorcontrib>Patel, Hetal Kiritkumar</creatorcontrib><creatorcontrib>Domaoal, Robert A.</creatorcontrib><creatorcontrib>Okoye, McPaul</creatorcontrib><creatorcontrib>Jelpe, Tapidiyel</creatorcontrib><creatorcontrib>Bronson, Megan</creatorcontrib><creatorcontrib>Ibrahim, Dalhatu</creatorcontrib><creatorcontrib>Swaminathan, Mahesh</creatorcontrib><creatorcontrib>Gambo, Aliyu</creatorcontrib><creatorcontrib>Charurat, Manhattan E.</creatorcontrib><creatorcontrib>NAIIS study group</creatorcontrib><creatorcontrib>the NAIIS study group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>HIV medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abimiku, Alash'le</au><au>Ramadhani, Habib Omari</au><au>Moloney, Mirna</au><au>Stafford, Kristen Alyce</au><au>Chang, Joy Chih‐Wei</au><au>Patel, Hetal Kiritkumar</au><au>Domaoal, Robert A.</au><au>Okoye, McPaul</au><au>Jelpe, Tapidiyel</au><au>Bronson, Megan</au><au>Ibrahim, Dalhatu</au><au>Swaminathan, Mahesh</au><au>Gambo, Aliyu</au><au>Charurat, Manhattan E.</au><aucorp>NAIIS study group</aucorp><aucorp>the NAIIS study group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Factors associated with viral suppression among adults living with HIV on antiretroviral therapy in Nigeria: Analysis of a population‐based survey, 2018</atitle><jtitle>HIV medicine</jtitle><addtitle>HIV Med</addtitle><date>2023-07</date><risdate>2023</risdate><volume>24</volume><issue>7</issue><spage>827</spage><epage>837</epage><pages>827-837</pages><issn>1464-2662</issn><issn>1468-1293</issn><eissn>1468-1293</eissn><abstract>Objective
Viral load suppression (VLS) is critical in reducing morbidity and mortality associated with HIV as well as minimizing the likelihood of HIV transmission to uninfected persons. The objective of this study was to identify factors associated with VLS among people living with HIV (PLWH) on antiretroviral (ARV) therapy to inform HIV programme strategies in Nigeria.
Methods
Adult participants, aged 15–64 years, from the 2018 Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS), who self‐reported to be a PLWH or had detectable ARVs, were analysed to examine factors associated with VLS defined as HIV RNA <1000 copies/mL. NAIIS measured HIV prevalence, viral load, ARV and hepatitis B in PLWH. Logistic regression models were used and reported weighted prevalence.
Results
Of 1322 participants, 949 (68.25%) were women and 1287 (96.82%) had detectable ARVs. The median age was 39.31 [interquartile range (IQR): 31.47–47.63] years. Prevalence of VLS was 80.88%. Compared with participants with detectable ARVs, those with undetectable ARVs in their blood specimens had lower odds of VLS [adjusted odds ratio (aOR) = 0.24, 95% confidence interval (CI): 0.08–0.64). Coinfection with hepatitis B and nonnucleoside reverse transcriptase inhibitor metabolites were also associated with lower odds of VLS. Older people (45–54 vs 15–24 years) had increased odds of VLS (aOR = 2.81, 95% CI: 1.14–6.90).
Conclusion
Young people and those with undetectable ARVs had lower odds of virological suppression. Targeted interventions focusing on young people and adherence to medication are needed to achieve the UNAIDS 95–95‐95 goals for HIV epidemic control.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>36945183</pmid><doi>10.1111/hiv.13485</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0001-9372-9359</orcidid><orcidid>https://orcid.org/0000-0001-5620-6436</orcidid><orcidid>https://orcid.org/0000-0002-0629-9459</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1464-2662 |
| ispartof | HIV medicine, 2023-07, Vol.24 (7), p.827-837 |
| issn | 1464-2662 1468-1293 1468-1293 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11195444 |
| source | MEDLINE; Access via Wiley Online Library |
| subjects | Acquired immune deficiency syndrome Acquired Immunodeficiency Syndrome - drug therapy Adolescent Adult Aged AIDS antiretroviral Antiretroviral agents Antiretroviral therapy Confidence intervals Disease transmission Epidemics Female Hepatitis Hepatitis B Hepatitis B - drug therapy HIV HIV Infections - drug therapy HIV Infections - epidemiology Human immunodeficiency virus Humans Male Metabolites Morbidity Nigeria - epidemiology Non-nucleoside reverse transcriptase inhibitors Older people people living with HIV Public health Regression analysis Regression models Reverse Transcriptase Inhibitors - therapeutic use RNA-directed DNA polymerase Statistical analysis survey Surveys Viral Load viral suppression Young adults |
| title | Factors associated with viral suppression among adults living with HIV on antiretroviral therapy in Nigeria: Analysis of a population‐based survey, 2018 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T11%3A13%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Factors%20associated%20with%20viral%20suppression%20among%20adults%20living%20with%20HIV%20on%20antiretroviral%20therapy%20in%20Nigeria:%20Analysis%20of%20a%20population%E2%80%90based%20survey,%202018&rft.jtitle=HIV%20medicine&rft.au=Abimiku,%20Alash'le&rft.aucorp=NAIIS%20study%20group&rft.date=2023-07&rft.volume=24&rft.issue=7&rft.spage=827&rft.epage=837&rft.pages=827-837&rft.issn=1464-2662&rft.eissn=1468-1293&rft_id=info:doi/10.1111/hiv.13485&rft_dat=%3Cproquest_pubme%3E2833865524%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2833865524&rft_id=info:pmid/36945183&rfr_iscdi=true |